Comparison of Paliperidone Palmitate and RISPERDAL CONSTA in Patients With Schizophrenia
Clinical trial NCT00589914 · COMPLETED
Trial details
- NCT number
- NCT00589914
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2009-06-01
- Enrollment
- 1221
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.